Antimicrobial-associated renal tubular acidosis

Brian A Hemstreet1

  • 1Department of Clinical Pharmacy, School of Pharmacy, University of Colorado, Box C238, Denver, CO 80262-0238, USA. Brian.Hemstreet@uchsc.edu

Abstract

Insights

Antimicrobial medications can rarely cause renal tubular acidosis (RTA), a kidney disorder. Amphotericin B, trimethoprim/sulfamethoxazole, and tetracycline are commonly implicated drugs.

Area of Science:

  • Nephrology
  • Pharmacology
  • Toxicology

Background:

  • Renal tubular acidosis (RTA) is a condition characterized by impaired kidney acid excretion.
  • Antimicrobial agents are essential for treating infections but can have adverse effects.
  • The association between specific antimicrobials and RTA requires careful clinical consideration.

Purpose of the Study:

  • To systematically review the medical literature for documented cases of RTA associated with antimicrobial medications.
  • To identify which classes and specific agents of antimicrobials are linked to RTA development.
  • To understand the mechanisms and clinical presentation of antimicrobial-induced RTA.

Main Methods:

  • Comprehensive literature search of MEDLINE and International Pharmaceutical Abstracts (1966-2003).
  • Inclusion of case reports, observational studies, and experimental studies in humans.
  • Keywords used: renal tubular acidosis, acidosis, antibiotics, and antimicrobials.

Main Results:

  • Antimicrobial-associated RTA is an uncommon adverse drug event.
  • Amphotericin B, trimethoprim/sulfamethoxazole, and outdated tetracycline are frequently reported culprits.
  • RTA can result from direct tubular toxicity or drug pharmacologic action, with variable onset and reversibility.

Conclusions:

  • Antimicrobial agents should be considered as potential causes of RTA, especially when other causes are not apparent.
  • Diagnosing drug-induced RTA can be challenging due to polypharmacy and inherent nephrotoxicity of some agents.
  • Thorough review of a patient's medication regimen is crucial for identifying unrecognized causes of RTA.

Related Concept Videos

Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...